PT  - JOURNAL ARTICLE
AU  - Lubinga, Solomon J
AU  - Payer, Tilman
AU  - Lee, Lydia
AU  - Gregg, Meghann
AU  - Allonby, Odette
AU  - García-Fernández, Llenalia
AU  - Hurteau, Jean
TI  - 589 RUBY trial post hoc analysis of number needed to treat and incremental costs per outcome of dostarlimab + carboplatin-paclitaxel (CP) vs placebo + CP for primary advanced/recurrent endometrial cancer
AID  - 10.1136/jitc-2023-SITC2023.0589
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A670--A670
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A670.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A670.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.